|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1996-10-21
|
|
pubmed:abstractText |
The clinical feasibility of radioimmunotherapy (RIAIT) was assessed in patients with metastatic, carcinoembryonic antigen (CEA)-producing cancers who had minimal residual or small-volume disease (tumor lesions < or = 3 cm in diameter).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1504-10
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8790202-Adult,
pubmed-meshheading:8790202-Aged,
pubmed-meshheading:8790202-Aged, 80 and over,
pubmed-meshheading:8790202-Carcinoembryonic Antigen,
pubmed-meshheading:8790202-Colorectal Neoplasms,
pubmed-meshheading:8790202-Dose-Response Relationship, Radiation,
pubmed-meshheading:8790202-Feasibility Studies,
pubmed-meshheading:8790202-Female,
pubmed-meshheading:8790202-Humans,
pubmed-meshheading:8790202-Iodine Radioisotopes,
pubmed-meshheading:8790202-Lung Neoplasms,
pubmed-meshheading:8790202-Male,
pubmed-meshheading:8790202-Middle Aged,
pubmed-meshheading:8790202-Radioimmunotherapy,
pubmed-meshheading:8790202-Radiotherapy Dosage
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2.
|
|
pubmed:affiliation |
Garden State Cancer Center, Center for Molecular Medicine and Immunology, Newark, New Jersey 07103, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
